Silencing ITGBL1 inhibits proliferation, migration, invasion, M2 macrophage polarization, and CD8+ T cell immunosuppression, while RBM15 deficiency significantly reduces tumor growth (Zhu et al., 2025) (Figure 4). The gene discussed is CD8A; the disease is neoplasm.